NCT07491588

Brief Summary

The average lifespan of individuals in many developed countries is increasing. This factor paired with the increase in global population has the potential to put a strain on healthcare systems with regards to age-related conditions. Particularly, this research considers the impact that conditions such as Parkinson's disease, dementia and stroke have on the walking capabilities on affected individuals. This research project aims to obtain a gait analysis dataset consisting of sensor data captured during regular daily activities on common terrains such as grass, paving slabs, gravel, etc. The dataset will be collected with a custom sensor system which captures mobility data from a cohort of healthy controls of all ages and people with dementia, Parkinson's disease, stroke survivors, multiple sclerosis, etc. Various machine learning algorithms (custom-implemented using Python) will then be used to determine the walking activity (walking, ramp ascend/descend, stair ascend/descend etc.), the terrain (grass, pavement, carpet etc.), and various walking-related parameters (step length, step height, cadence etc.). It is our hope that these features will enable remote gait analysis to be performed with sufficient contextual information to enable remote diagnosis and rehabilitation tracking for those at risk of falling.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2025

Shorter than P25 for all trials

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 15, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

March 1, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
9 months until next milestone

First Posted

Study publicly available on registry

March 24, 2026

Completed
Last Updated

March 24, 2026

Status Verified

March 1, 2026

Enrollment Period

4 months

First QC Date

November 15, 2024

Last Update Submit

March 18, 2026

Conditions

Keywords

Gait analysisSensor systemLong-term health condition

Outcome Measures

Primary Outcomes (1)

  • Number of participants to complete gait analysis using the All-terrain Gait Analysis System

    The number of participants who are able to complete all elements of the All-terrain Gait Analysis System, which is a mobile gait analysis system to analyse gait in the environment, will be recorded to assess the feasibility of using the system in a larger observational study.

    From enrollment to the completion of the gait analysis.

Study Arms (1)

Gait analysis

Group whose gait is being analysed

Device: All-terrain Gait Analysis System

Interventions

Mobile gait analysis system for environmental gait analysis

Gait analysis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients attending the rehabilitation clinic at Chapel Allerton Hospital in Leeds, UK

You may qualify if:

  • Age \> 18 years
  • Confirmed diagnosis of Parkinson's disease, dementia, acquired brain injury (stroke, cerebral palsy, etc.), multiple sclerosis, or have had a lower limb amputation.
  • Under the care of a Leeds consultant or specialist nurse
  • Able to walk indoors and outdoors without a walking aid

You may not qualify if:

  • Age \< 18 years
  • Skin condition on feet, ankles, or waist that prevents wearing the sensor system.
  • Cognitive impairment causing inability to consent.
  • Unable to walk safely with provided shoes (need for specialist shoes).
  • Allergy to silicone or elastic fibres

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Parkinson DiseaseParkinsonian DisordersDementiaBrain InjuriesMultiple SclerosisWounds and Injuries

Condition Hierarchy (Ancestors)

Basal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersCraniocerebral TraumaTrauma, Nervous SystemDemyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Rory J O'Connor, MD

    University of Leeds

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Charterhouse Professor of Rehabilitation Medicine

Study Record Dates

First Submitted

November 15, 2024

First Posted

March 24, 2026

Study Start

March 1, 2025

Primary Completion

July 1, 2025

Study Completion

July 1, 2025

Last Updated

March 24, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share